About this trial
Transcranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profile, and good efficacy in the contexts where it has been the subject of dedicated research: neuropathic pain, fibromyalgia, and visceral pain. Few studies have focused on the application of tDCS in the context of complex regional pain syndrome (CRPS), which is a common condition.
Eligibility criteria
Qualifiers
Major
Clinically active or active complex regional pain syndrome (CRPS) with positive Budapest criteria
Scintigraphy showing signs consistent with CRPS
Being affiliated with or a beneficiary of a social security scheme
Disqualifiers
Algodystrophy no longer meeting the Budapest criteria
Relative contraindication to tDCS: psychosis (including treated psychosis), uncontrolled epilepsy, large scalp scar, intracerebral/intracranial metallic body
Pregnant or breastfeeding women
Minors
Trial design
Treatments tested in this trial
- transcranial direct current stimulation
- Placebo